A deep dive into a strain: Blue Dream. Looking at its history, genetic lineage, chemical composition, effects and other data related insights.

This week I perform a big data analysis on one of the largest datasets regarding customer feedback on the cannabis industry to find out, “what is it about a cannabis product or strain that makes people more happy?” This is the first of several podcast on this topic.

Former FDA Deputy Peter Pitts joins us for an exclusive look at the historic hearings before Congress regarding the regulation of CBD across the market place. Pitts is also President of the Center for Medicine in the Public Interest and will discuss what recreational consumers and medicinal users can do to stay ahead of regulation.

As of October 17th, a G7 economy is opening its doors to a brand new billion dollar market, overnight. Canada will become the world’s first major economy to legalize the commodity market for hemp and cannabis, creating over $7.2 billion dollars in opportunities that have never been tested or regulated at this scale. Since there is no precedent for this, it is critical that everyone, from growers to retailers to investors, have the latest facts and analysis that can impact their business sense and decisions.

Introduction to Markets with Memory, my background, and my love for my grandmother.